5 Common GCP Mistakes That Trigger FDA Warning Letters
https://zenovel.com/5-common-g....cp-mistakes-that-tri
Avoiding common Good Clinical Practice (GCP) mistakes is essential for maintaining regulatory compliance, protecting patient safety, and ensuring data integrity in clinical trials. Even minor errors in documentation, informed consent, protocol adherence, or investigator oversight can lead to serious consequences, including regulatory observations, warning letters, trial delays, and reputational damage. Regulatory authorities such as the FDA, EMA, and MHRA closely evaluate compliance standards